Please enable JavaScript to continue using this application.

Compare $GRAL vs $IOVA | Chartloom

Compare

$GRAL vs $IOVA

Grail Inc · Iovance Biotherapeutics Inc

GRAL

Grail Inc

IOVA

Iovance Biotherapeutics Inc

Compare $GRAL vs $IOVA

Comparing Grail Inc and Iovance Biotherapeutics Inc

GRALGrail Inc

IOVAIovance Biotherapeutics Inc

GRALGrail Inc

Market cap

$6.03B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

29.71x

Rev growth (TTM)

23.1%

YTD performance

58.2%

52W performance

123.8%

FCF yield

-4.9%

IOVAIovance Biotherapeutics Inc

Market cap

$6.53B

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

12.69x

Rev growth (TTM)

34.5%

YTD performance

480.2%

52W performance

544.1%

FCF yield

-4.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

GRAL

IOVA

Detailed metrics comparison

GRAL

Grail Inc

IOVA

Iovance Biotherapeutics Inc

Market Cap

GRAL$6.03B

IOVA$6.53B

Enterprise Value

GRAL$5.98B

IOVA$6.42B

Price

GRAL$140.58

IOVA$14.62

P/E Ratio

GRALN/A

IOVAN/A

P/S Ratio

GRAL36.51x

IOVA20.09x

EV/Sales

GRAL36.17x

IOVA19.75x

EV/EBITDA

GRAL0.00x

IOVA0.00x

P/B Ratio

GRAL2.52x

IOVA8.75x

P/FCF Ratio

GRALN/A

IOVAN/A

EV/FCF

GRAL-20.19x

IOVA-21.65x

PEG Ratio

GRALN/A

IOVAN/A

Forward P/E (NTM)

GRALN/A

IOVAN/A

Forward P/S (NTM)

GRAL29.71x

IOVA12.69x

Revenue (TTM)

GRAL$165M

IOVA$325M

Revenue Growth (YoY)

GRAL23.1%

IOVA34.5%

Forward Rev Growth

GRAL25.3%

IOVA39.2%

Gross Margin (TTM)

GRAL49.7%

IOVA48.4%

Operating Margin (TTM)

GRAL0.0%

IOVA0.0%

EBITDA Margin (TTM)

GRAL-229.0%

IOVA-79.8%

Net Margin (TTM)

GRAL-236.9%

IOVA-89.1%

FCF Margin (TTM)

GRAL-179.2%

IOVA-91.2%

Net Income (TTM)

GRAL$-392M

IOVA$-290M

FCF (TTM)

GRAL$-296M

IOVA$-296M

EPS (TTM)

GRAL-$9.08

IOVA-$0.64

ROE (TTM)

GRAL-1588.0%

IOVA-4051.0%

ROA (TTM)

GRAL-1402.0%

IOVA-3165.0%

ROIC (TTM)

GRAL-1588.0%

IOVA-4047.0%

Cash

GRAL$56M

IOVA$111M

Debt

GRAL$0

IOVA$0

Net Cash/Debt

GRAL$56M

IOVA$111M

Current Ratio (TTM)

GRAL10.95x

IOVA4.35x

Quick Ratio (TTM)

GRAL10.55x

IOVA3.74x

Debt/Equity (TTM)

GRAL0.00x

IOVA0.00x

Debt/Assets (TTM)

GRAL0.0%

IOVA0.0%

Interest Coverage (TTM)

GRALN/A

IOVAN/A

Net Debt/EBITDA (TTM)

GRAL0.00x

IOVA0.00x

Beta

GRAL2.04

IOVA0.76

52W Performance

GRAL123.8%

IOVA544.1%

YTD Performance

GRAL58.2%

IOVA480.2%

% from 52W High

GRAL-15.6%

IOVA-4.4%

% from 52W Low

GRAL238.7%

IOVA730.7%

Asset Turnover (TTM)

GRAL0.06x

IOVA0.36x

FCF Yield (TTM)

GRAL-4.9%

IOVA-4.5%

Earnings Yield (TTM)

GRAL-6.5%

IOVA-4.4%

Dividend Yield (TTM)

GRALN/A

IOVAN/A

Rule of 40

GRAL-156.1

IOVA-56.7

EV/GP/RG

GRAL2.75

IOVA0.68

Ticker research

View GRAL research View IOVA research

Metric	GRAL Grail Inc	IOVA Iovance Biotherapeutics Inc
Market & Valuation
Market Cap	$6.03B	$6.53B
Enterprise Value	$5.98B	$6.42B
Price	$140.58	$14.62
P/E Ratio	N/A	N/A
P/S Ratio	36.51x	20.09x
EV/Sales	36.17x	19.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.52x	8.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-20.19x	-21.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	29.71x	12.69x
Revenue & Growth
Revenue (TTM)	$165M	$325M
Revenue Growth (YoY)	23.1%	34.5%
Forward Rev Growth	25.3%	39.2%
Profitability
Gross Margin (TTM)	49.7%	48.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-229.0%	-79.8%
Net Margin (TTM)	-236.9%	-89.1%
FCF Margin (TTM)	-179.2%	-91.2%
Net Income (TTM)	$-392M	$-290M
FCF (TTM)	$-296M	$-296M
EPS (TTM)	-$9.08	-$0.64
ROE (TTM)	-1588.0%	-4051.0%
ROA (TTM)	-1402.0%	-3165.0%
ROIC (TTM)	-1588.0%	-4047.0%
Financial Health
Cash	$56M	$111M
Debt	$0	$0
Net Cash/Debt	$56M	$111M
Current Ratio (TTM)	10.95x	4.35x
Quick Ratio (TTM)	10.55x	3.74x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.04	0.76
52W Performance	123.8%	544.1%
YTD Performance	58.2%	480.2%
% from 52W High	-15.6%	-4.4%
% from 52W Low	238.7%	730.7%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.36x
FCF Yield (TTM)	-4.9%	-4.5%
Earnings Yield (TTM)	-6.5%	-4.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-156.1	-56.7
EV/GP/RG	2.75	0.68
Ticker research	View GRAL research	View IOVA research

Valuation

P/S Ratio

IOVA

20.09x

GRAL

36.51x

EV/FCF

IOVA

-21.65x

GRAL

-20.19x

Growth & revenue

Revenue Growth TTM

IOVA

34.5%

GRAL

23.1%

Forward Revenue Growth

IOVA

39.2%

GRAL

25.3%

Profitability & performance

Gross Margin

GRAL

49.7%

IOVA

48.4%

ROE

GRAL

-1588.0%

IOVA

-4051.0%

FCF Yield %

IOVA

-4.5%

GRAL

-4.9%

52-Week Performance

IOVA

544.1%

GRAL

123.8%

Detailed metrics comparison

GRAL

Grail Inc

IOVA

Iovance Biotherapeutics Inc

Market Cap

GRAL$6.03B

IOVA$6.53B

Enterprise Value

GRAL$5.98B

IOVA$6.42B

Price

GRAL$140.58

IOVA$14.62

P/E Ratio

GRALN/A

IOVAN/A

P/S Ratio

GRAL36.51x

IOVA20.09x

EV/Sales

GRAL36.17x

IOVA19.75x

EV/EBITDA

GRAL0.00x

IOVA0.00x

P/B Ratio

GRAL2.52x

IOVA8.75x

P/FCF Ratio

GRALN/A

IOVAN/A

EV/FCF

GRAL-20.19x

IOVA-21.65x

PEG Ratio

GRALN/A

IOVAN/A

Forward P/E (NTM)

GRALN/A

IOVAN/A

Forward P/S (NTM)

GRAL29.71x

IOVA12.69x

Revenue (TTM)

GRAL$165M

IOVA$325M

Revenue Growth (YoY)

GRAL23.1%

IOVA34.5%

Forward Rev Growth

GRAL25.3%

IOVA39.2%

Gross Margin (TTM)

GRAL49.7%

IOVA48.4%

Operating Margin (TTM)

GRAL0.0%

IOVA0.0%

EBITDA Margin (TTM)

GRAL-229.0%

IOVA-79.8%

Net Margin (TTM)

GRAL-236.9%

IOVA-89.1%

FCF Margin (TTM)

GRAL-179.2%

IOVA-91.2%

Net Income (TTM)

GRAL$-392M

IOVA$-290M

FCF (TTM)

GRAL$-296M

IOVA$-296M

EPS (TTM)

GRAL-$9.08

IOVA-$0.64

ROE (TTM)

GRAL-1588.0%

IOVA-4051.0%

ROA (TTM)

GRAL-1402.0%

IOVA-3165.0%

ROIC (TTM)

GRAL-1588.0%

IOVA-4047.0%

Cash

GRAL$56M

IOVA$111M

Debt

GRAL$0

IOVA$0

Net Cash/Debt

GRAL$56M

IOVA$111M

Current Ratio (TTM)

GRAL10.95x

IOVA4.35x

Quick Ratio (TTM)

GRAL10.55x

IOVA3.74x

Debt/Equity (TTM)

GRAL0.00x

IOVA0.00x

Debt/Assets (TTM)

GRAL0.0%

IOVA0.0%

Interest Coverage (TTM)

GRALN/A

IOVAN/A

Net Debt/EBITDA (TTM)

GRAL0.00x

IOVA0.00x

Beta

GRAL2.04

IOVA0.76

52W Performance

GRAL123.8%

IOVA544.1%

YTD Performance

GRAL58.2%

IOVA480.2%

% from 52W High

GRAL-15.6%

IOVA-4.4%

% from 52W Low

GRAL238.7%

IOVA730.7%

Asset Turnover (TTM)

GRAL0.06x

IOVA0.36x

FCF Yield (TTM)

GRAL-4.9%

IOVA-4.5%

Earnings Yield (TTM)

GRAL-6.5%

IOVA-4.4%

Dividend Yield (TTM)

GRALN/A

IOVAN/A

Rule of 40

GRAL-156.1

IOVA-56.7

EV/GP/RG

GRAL2.75

IOVA0.68

Ticker research

View GRAL research View IOVA research

Metric	GRAL Grail Inc	IOVA Iovance Biotherapeutics Inc
Market & Valuation
Market Cap	$6.03B	$6.53B
Enterprise Value	$5.98B	$6.42B
Price	$140.58	$14.62
P/E Ratio	N/A	N/A
P/S Ratio	36.51x	20.09x
EV/Sales	36.17x	19.75x
EV/EBITDA	0.00x	0.00x
P/B Ratio	2.52x	8.75x
P/FCF Ratio	N/A	N/A
EV/FCF	-20.19x	-21.65x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	29.71x	12.69x
Revenue & Growth
Revenue (TTM)	$165M	$325M
Revenue Growth (YoY)	23.1%	34.5%
Forward Rev Growth	25.3%	39.2%
Profitability
Gross Margin (TTM)	49.7%	48.4%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-229.0%	-79.8%
Net Margin (TTM)	-236.9%	-89.1%
FCF Margin (TTM)	-179.2%	-91.2%
Net Income (TTM)	$-392M	$-290M
FCF (TTM)	$-296M	$-296M
EPS (TTM)	-$9.08	-$0.64
ROE (TTM)	-1588.0%	-4051.0%
ROA (TTM)	-1402.0%	-3165.0%
ROIC (TTM)	-1588.0%	-4047.0%
Financial Health
Cash	$56M	$111M
Debt	$0	$0
Net Cash/Debt	$56M	$111M
Current Ratio (TTM)	10.95x	4.35x
Quick Ratio (TTM)	10.55x	3.74x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.04	0.76
52W Performance	123.8%	544.1%
YTD Performance	58.2%	480.2%
% from 52W High	-15.6%	-4.4%
% from 52W Low	238.7%	730.7%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.36x
FCF Yield (TTM)	-4.9%	-4.5%
Earnings Yield (TTM)	-6.5%	-4.4%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-156.1	-56.7
EV/GP/RG	2.75	0.68
Ticker research	View GRAL research	View IOVA research